Stock listing
Euronext:ALTHX THX Pharma Action
Home listing (Euronext) of THX Pharma
Follow THX Pharma into a list and get an email when it puts out news.
Share price · EURONEXT:ALTHX
€2.97 EUR -0.24 (-7.5%)
Close on Nov 20, 2026
- Day range
- €2.96 – €3.21 EURNov 20, 2026
- Volume
- 85,934 sharesNov 20, 2026
- Market cap
- €43.03M EURAt the close on Nov 20, 2026 · price × 14.49M shares outstanding
- 52-week range
- €1.49 – €5.10 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €220,397 EURMedian day 46,650 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ALTHX · Home | €2.97 EUR | -0.24 (-7.5%) | 85,934 | €3.21 | €3.21 | €2.955 | €3.21 | Close on Nov 20, 2026 |
| Frankfurt:3VG | €3.11 EUR | +0.03 (+1.0%) | — | €3.11 | €3.11 | €3.11 | €3.08 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:ALTHX · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €2.97 | -0.24 | -7.5% | €3.21 | €3.21 | €2.955 | 85,934 | |
| €3.21 | +0.035 | +1.1% | €3.19 | €3.32 | €3.19 | 29,469 | |
| €3.175 | -0.095 | -2.9% | €3.25 | €3.26 | €3.15 | 28,577 | |
| €3.27 | -0.05 | -1.5% | €3.32 | €3.325 | €3.19 | 47,821 | |
| €3.32 | -0.16 | -4.6% | €3.48 | €3.48 | €3.275 | 50,135 | |
| €3.48 | -0.02 | -0.6% | €3.50 | €3.56 | €3.345 | 41,651 | |
| €3.50 | +0.08 | +2.3% | €3.40 | €3.58 | €3.36 | 63,677 | |
| €3.42 | +0.09 | +2.7% | €3.35 | €3.45 | €3.305 | 41,196 | |
| €3.33 | +0.13 | +4.1% | €3.21 | €3.33 | €3.21 | 25,639 | |
| €3.20 | -0.06 | -1.8% | €3.22 | €3.25 | €3.045 | 73,280 | |
| €3.26 | -0.18 | -5.2% | €3.40 | €3.40 | €3.195 | 68,810 | |
| €3.44 | +0.04 | +1.2% | €3.38 | €3.45 | €3.28 | 82,550 | |
| €3.40 | +0.075 | +2.3% | €3.28 | €3.40 | €3.205 | 35,799 | |
| €3.325 | +0.015 | +0.5% | €3.25 | €3.325 | €3.205 | 30,662 | |
| €3.31 | -0.17 | -4.9% | €3.48 | €3.48 | €3.28 | 73,733 | |
| €3.48 | +0.02 | +0.6% | €3.495 | €3.495 | €3.385 | 45,435 | |
| €3.46 | +0.13 | +3.9% | €3.35 | €3.51 | €3.315 | 59,648 | |
| €3.33 | +0.06 | +1.8% | €3.25 | €3.33 | €3.23 | 32,365 | |
| €3.27 | +0.11 | +3.5% | €3.16 | €3.285 | €3.16 | 16,943 | |
| €3.16 | -0.04 | -1.3% | €3.24 | €3.27 | €3.16 | 42,670 | |
| €3.20 | -0.13 | -3.9% | €3.33 | €3.36 | €3.18 | 39,217 | |
| €3.33 | +0.05 | +1.5% | €3.32 | €3.395 | €3.275 | 33,211 | |
| €3.28 | +0.07 | +2.2% | €3.21 | €3.28 | €3.105 | 29,586 | |
| €3.21 | +0.08 | +2.6% | €3.15 | €3.21 | €3.09 | 21,014 | |
| €3.13 | -0.08 | -2.5% | €3.21 | €3.28 | €3.12 | 42,044 | |
| €3.21 | +0.21 | +7.0% | €2.96 | €3.25 | €2.95 | 57,080 | |
| €3.00 | -0.035 | -1.2% | €3.015 | €3.09 | €2.99 | 34,546 | |
| €3.035 | -0.055 | -1.8% | €3.11 | €3.135 | €3.035 | 10,534 | |
| €3.09 | +0.015 | +0.5% | €3.09 | €3.13 | €3.05 | 15,694 | |
| €3.075 | +0.095 | +3.2% | €3.00 | €3.075 | €2.99 | 35,840 | |
| €2.98 | -0.27 | -8.3% | €3.25 | €3.25 | €2.97 | 80,252 | |
| €3.25 | -0.02 | -0.6% | €3.245 | €3.325 | €3.245 | 34,978 | |
| €3.27 | +0.13 | +4.1% | €3.14 | €3.30 | €3.14 | 42,490 | |
| €3.14 | -0.02 | -0.6% | €3.14 | €3.14 | €2.92 | 82,687 | |
| €3.16 | -0.24 | -7.1% | €3.32 | €3.32 | €3.06 | 146,959 | |
| €3.40 | -0.01 | -0.3% | €3.37 | €3.45 | €3.295 | 72,237 | |
| €3.41 | -0.115 | -3.3% | €3.57 | €3.57 | €3.295 | 110,295 | |
| €3.525 | +0.14 | +4.1% | €3.42 | €3.60 | €3.42 | 97,780 | |
| €3.385 | -0.015 | -0.4% | €3.385 | €3.455 | €3.38 | 41,394 | |
| €3.40 | -0.02 | -0.6% | €3.39 | €3.455 | €3.35 | 56,189 | |
| €3.42 | +0.06 | +1.8% | €3.38 | €3.57 | €3.35 | 91,187 | |
| €3.36 | +0.02 | +0.6% | €3.36 | €3.41 | €3.34 | 37,045 | |
| €3.34 | -0.01 | -0.3% | €3.35 | €3.35 | €3.27 | 39,472 | |
| €3.35 | -0.08 | -2.3% | €3.41 | €3.425 | €3.345 | 45,479 | |
| €3.43 | +0.13 | +3.9% | €3.32 | €3.465 | €3.305 | 52,980 | |
| €3.30 | +0.04 | +1.2% | €3.25 | €3.34 | €3.25 | 48,260 | |
| €3.26 | +0.02 | +0.6% | €3.25 | €3.34 | €3.23 | 57,471 | |
| €3.24 | -0.10 | -3.0% | €3.36 | €3.36 | €3.20 | 62,842 | |
| €3.34 | +0.015 | +0.5% | €3.36 | €3.43 | €3.31 | 55,069 | |
| €3.325 | -0.055 | -1.6% | €3.40 | €3.44 | €3.30 | 94,317 | |
| €3.38 | -0.10 | -2.9% | €3.465 | €3.545 | €3.38 | 75,547 | |
| €3.48 | -0.29 | -7.7% | €3.89 | €3.92 | €3.42 | 392,499 | |
| €3.77 | -0.06 | -1.6% | €3.84 | €3.86 | €3.76 | 33,248 | |
| €3.83 | +0.04 | +1.1% | €3.80 | €3.865 | €3.72 | 77,495 | |
| €3.79 | -0.05 | -1.3% | €3.88 | €3.88 | €3.725 | 74,215 | |
| €3.84 | -0.29 | -7.0% | €4.08 | €4.10 | €3.83 | 211,065 | |
| €4.13 | +0.03 | +0.7% | €4.39 | €4.39 | €4.005 | 196,552 | |
| €4.10 | -0.035 | -0.8% | €4.21 | €4.21 | €4.005 | 38,377 | |
| €4.135 | -0.09 | -2.1% | €4.24 | €4.24 | €4.12 | 43,882 | |
| €4.225 | +0.095 | +2.3% | €4.15 | €4.335 | €4.15 | 72,403 | |
| €4.13 | -0.10 | -2.4% | €4.22 | €4.25 | €4.11 | 38,196 | |
| €4.23 | +0.055 | +1.3% | €4.16 | €4.36 | €4.11 | 100,631 | |
| €4.175 | +0.085 | +2.1% | €4.135 | €4.19 | €4.135 | 15,258 | |
| €4.09 | -0.145 | -3.4% | €4.235 | €4.235 | €4.09 | 37,186 | |
| €4.235 | -0.045 | -1.1% | €4.275 | €4.32 | €4.14 | 43,558 | |
| €4.28 | -0.13 | -2.9% | €4.425 | €4.47 | €4.16 | 62,468 |
Splits
1 split · EURONEXT:ALTHX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 26-for-25 | Split |
- Ticker
- Euronext:ALTHX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Euronext
- Currency
- EUR
What changed lately
Latest news release · Nov 10, 2026
Bilan semestriel du contrat de liquidité confié à portzamparc
Latest news
Bilan semestriel du contrat de liquidité confié à portzamparc
Nov 10, 2026
Closed €3.42 (+2.7%) on Nov 10, 2026
THX Pharma Reports Its Cash Position as of September 30, 2026
Oct 22, 2026
Closed €3.20 (-3.9%) on Oct 22, 2026
THX Pharma: THX Pharma reports its financial results for the first half of 2026
Sep 29, 2026
Closed €3.41 (-3.3%) on Sep 30, 2026
THX Pharma reports its financial results for the first half of 2026
Sep 29, 2026
Closed €3.53 (+4.1%) on Sep 29, 2026
THX Pharma annonce ses resultats financiers du premier semestre 2026
Sep 29, 2026
Closed €3.53 (+4.1%) on Sep 29, 2026
Rapport semestriel THX Pharma
Sep 29, 2026
Closed €3.53 (+4.1%) on Sep 29, 2026
THX Pharma: Corrected press release: THX Pharma and the Beyond Batten Disease Foundation Announce the Grant of a European Patent Protecting the Use of Batten-1 in Juvenile Batten Disease (CLN3)
Sep 9, 2026
Closed €3.48 (-7.7%) on Sep 9, 2026
THX Pharma: THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in Juvenile Batten Disease (CLN3)
Sep 1, 2026
Closed €4.13 (+0.7%) on Sep 2, 2026
THX Pharma: THX Pharma Reports Cash Position as of June 30, 2026
Jul 9, 2026
Closed €3.74 (+4.8%) on Jul 10, 2026
THX Pharma: THX Pharma Announces the Appointment of Sophie Jacq Lapointe to its Board of Directors
Jun 23, 2026
Closed €3.33 (+0.2%) on Jun 24, 2026
Financings
Rights offering of new shares with shareholders' preferential subscription rights
Nov 13, 2025 · US$9.13M
Closed: €7.84M raised · €1.8 a share · Portzamparc BNP Paribas
Dealers: Portzamparc BNP Paribas (lead)
Buyers: Funds managed by Odyssée Venture (3 500 000 € commitment); Market Wizards B.V. (194,443 shares for €349,997.40 as guarantor); TreeCap B.V. (175,000 shares for €315,000.00 as guarantor); Gestys (155,555 shares for €279,999.00 as guarantor); Friedland Gestion (136,110 New Shares for €244,998.00 as guarantor); Maitice Gestion (97,221 New Shares for €174,997.80 as guarantor); Multi stratégies SA - SICAV RAIF (58,333 New Shares for €104,999.40 as guarantor); Auriga Partners (55,555 New Shares for €99,999.00 as guarantor); Allia-Tech Asset Management (46,349 New Shares for €83,428.20 as guarantor); Montpensier-Arbevel (guarantee commitment of €50,000); Samuel Fisher (subscription commitment of €50,000); Mathieu Charvériat (10 000 € commitment); Fonds gérés par Odyssée Venture (1,699,531 shares for €3,059,155.80 as guarantor); Samuel Fischer (27,777 New Shares for €49,998.60 as guarantor)
Insiders: CEO Mathieu Charvériat and CFO Christine Placet each committed 10 000 €
Use of proceeds: To develop and commercialize its two assets, Batten-1 and TX01, and its antisense oligonucleotide platform
Decks
Theranexus — Investor Access Conference (April 2024)
Conference · 18 slides · Apr 5, 2024
Theranexus — Investor Presentation (September 2023)
Investor deck · 17 slides · Sep 29, 2023
Theranexus — Investor Presentation (September 2023)
Investor deck · 16 slides · Sep 29, 2023
Theranexus — Investor Presentation (June 2023)
Investor deck · 18 slides · June 2023
THX Pharma on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 28 in all · newest Nov 10, 2026 · oldest 2025
- Decks
- 21 decks · latest Apr 5, 2024
Where THX Pharma is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ALTHX · Home listing · This page | Euronext | France | EUR |
| gettex:3VG | gettex | Germany | EUR |
| LS Exchange:A2H6LX | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2H6LX | Lang & Schwarz | Germany | EUR |
| Frankfurt:3VG | Frankfurt | Germany | EUR |
| Munich:3VG | Munich | Germany | EUR |
| Turquoise:ALTHXP | Turquoise | United Kingdom | EUR |
| Stuttgart:3VG | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about THX Pharma.